Understanding FSHD & fshdcare.com
A comprehensive guide to Facioscapulohumeral Muscular Dystrophy, genetic pathology, DUX4 toxic gene expression, diagnostic evaluation protocols, and connecting with global clinical trial networks.
What is FSHD?
Facioscapulohumeral Muscular Dystrophy (FSHD) is a genetic muscle disorder characterized by progressive muscle weakness. It primarily affects facial muscles, shoulder blades (scapula), and upper arms (humerus). Symptoms usually appear in teenagers or young adults, but onset varies widely.
- Asymmetric facial muscle weakness (inability to whistle or puff cheeks)
- Characteristic scapular winging & humeral arm weakness
- Selective abdominal muscle involvement (Beevor's Sign)
Purpose of fshdcare.com
fshdcare.com is an independent global directory connecting patients, families, and healthcare providers directly with accredited CTRN clinical trial research sites, expert genetic reference laboratories, and trained neuromuscular diagnostic neurologists worldwide.
Genetics & Disease Mechanism
FSHD is caused by toxic expression of the DUX4 gene in skeletal muscle. FSHD1 (95% of cases) results from contraction of D4Z4 repeats on chromosome 4q35 (1 to 10 repeats) with a permissive 4qA allele. FSHD2 (5% of cases) involves D4Z4 hypomethylation caused by mutations in SMCHD1 or DNMT3B genes.
Clinical Trial Research Network (CTRN)
The Clinical Trial Research Network (CTRN) is an international consortium of academic medical centers dedicated to accelerating clinical trial readiness, natural history studies, and therapeutic evaluations for FSHD patients across North America, Europe, and Asia-Pacific.
FSHD Society
The FSHD Society is the world's largest research-focused patient organization for FSHD. They empower patients by providing educational resources, local support chapters, international research funding, and navigation support to find clinical trials and accredited diagnostic providers.
Clinical Diagnostic Journey
Step-by-step diagnostic workflow for clinical practitioners and patients.
Clinical Neuromuscular Evaluation
Trained neurologists evaluate asymmetrical facial weakness, scapular fixation, humeral strength, and abdominal reflexes (Beevor's Sign).
Molecular Genetic Testing
Confirmation requires specialized laboratories performing D4Z4 Southern Blot Analysis, BsaAI digestion assays, or Optical Genome Mapping (OGM).
Multidisciplinary Care & CTRN Trial Referral
Patients are connected with university specialty centers for respiratory, orthopedic, physical therapy care, and registry enrollment.